HUTCHISON MEDIPHARMA LIMITED
33Patents
33Active
33Granted
56Portfolio score
Filing activity: Apr 27, 2010 → Apr 17, 2023 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9346810B2 | Pyrrolopyrimidine compounds and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US8507487B2 | Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor | Chemistry; Metallurgy | 8 | Active |
| US10208066B2 | Imidazopyridazine compounds and their use | Chemistry; Metallurgy | 3 | Active |
| US10519142B2 | Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide | Chemistry; Metallurgy | 2 | Active |
| US11046674B2 | Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide | Chemistry; Metallurgy | 1 | Active |
| US9181264B2 | Fused heteroaryls and their uses | Chemistry; Metallurgy | 1 | Active |
| US9956218B2 | Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor | Chemistry; Metallurgy | 1 | Active |
| US10052330B2 | Substituted pyrido[3,4-b]pyrazines as Syk inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9434726B2 | Substituted pyrido[3,4-b]pyrazines as Syk inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10512645B2 | Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor | Chemistry; Metallurgy | 1 | Active |
| US8987269B2 | Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor | Chemistry; Metallurgy | 1 | Active |
| US11478474B2 | 2-(3′-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4′-bipyridin]-2′-yl)-7,7-dimethyl-7,8-dihydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one as a BTK inhibitor | Chemistry; Metallurgy | 1 | Active |
| US10111875B2 | Pyrrolopyrimidine compounds and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12180214B2 | Crystalline forms of (s)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazine-7-yl)ethyl)amino)pyrimidine-5-carbonitrile as inhibitors of phosphatidylinositol-3-kinase | Chemistry; Metallurgy | 0 | Active |
| US11584750B2 | Crystalline forms of (S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazine-7-yl)ethyl)amino)pyrimidine-5-carbonitrile as inhibitors of phosphatidylinositol-3-kinase | Chemistry; Metallurgy | 0 | Active |
| US11396507B2 | Salts of a compound and the crystalline forms thereof | Chemistry; Metallurgy | 0 | Active |
| US10946014B2 | Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor | Chemistry; Metallurgy | 0 | Active |
| US12173008B2 | Substituted piperazines as BTK inhibitors | Human Necessities | 0 | Active |
| US10611777B2 | Imidazopyridazine compounds and their use | Chemistry; Metallurgy | 0 | Active |
| US11655254B2 | Substituted piperazines as BTK inhibitors | Human Necessities | 0 | Active |
| US8658658B2 | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | Human Necessities | 0 | Active |
| US9168253B2 | Quinazoline compounds | Chemistry; Metallurgy | 0 | Active |
| US12070457B2 | Substituted pyridines, pyridazines, pyrimidines, and 1,2,3-triazines as bruton's tyrosine kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12134613B2 | Method for the manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and polymorphic forms thereof | Chemistry; Metallurgy | 0 | Active |
| US10369153B2 | Pyrrolopyrimidine compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.